Position in GMAB
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$66,037,805
+$24,911,397 QoQ
Shares Held
2,461,342
+84.3% QoQ
Ownership
0.401%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in GMAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FIRST TRUST ADVISORS LP holds $2,375,392,616 across 80 Biotechnology names. GMAB ranks #18 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
346,855 | $267,994,047 | |
| 2 | INCY |
Incyte Corp
|
1,500,792 | $141,254,543 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
306,461 | $136,847,094 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
382,701 | $126,624,279 | |
| 5 | MRNA |
Moderna, Inc.
|
2,392,693 | $121,548,804 | |
| 6 | EXEL |
Exelixis, Inc.
|
2,534,992 | $108,725,806 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
577,479 | $97,605,500 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
1,482,340 | $95,803,634 |
All Filings in GMAB
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $66,037,805 | 2,461,342 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $41,126,408 | 1,335,273 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $51,752,189 | 1,687,388 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $36,574,604 | 1,770,310 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $33,478,001 | 1,709,806 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $34,316,290 | 1,644,288 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $33,962,485 | 1,393,047 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $30,381,491 | 1,208,973 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $36,776,438 | 1,229,570 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $40,439,824 | 1,270,095 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $38,613,701 | 1,094,803 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $45,387,969 | 1,194,106 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $48,143,735 | 1,274,993 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $50,650,584 | 1,195,153 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $41,495,895 | 1,291,500 | Shares | Sole | 2022-11-14 | |
| 2022-03-31 | $2,805,324 | 77,538 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $5,715,589 | 144,479 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $13,798,974 | 315,766 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $19,618,325 | 480,488 | Shares | Sole | 2021-10-12 | |
| 2020-12-31 | $29,262,514 | 719,688 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $13,406,765 | 366,205 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $4,669,059 | 137,771 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $1,390,911 | 65,640 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||